2026-10-13T19:07:25Z
https://api.figshare.com/v2/oai
oai:figshare.com:article/34036040
2026-09-30T17:43:04Z
category_7
category_21
category_64
category_106
portal_5
item_type_6
month_year_09_2026
<p>PRISMA 2020 Checklist.</p>
Maureen Moyo-Chilufya (3947999)
Arthemon Nguweneza (17133386)
Sara Rotenberg (15877462)
Hannah Kuper (25751)
Tracey Smythe (4596409)
Medicine
Biotechnology
Cancer
Science Policy
>&# 964 ;</
studies reporting age
effect measures used
29 studies met
>< sup ><
xlink "> mortality
excluded studies without
xlink "> children
synthesise current evidence
reported heterogeneity using
35 million children
disaggregated mortality data
cause mortality rates
ascertain disability ascertainment
included cohort studies
98 %) higher
35 ]; p
mortality among children
adjusted mortality ratios
peers without disabilities
2 </ sup
hr )= 7
analysis </ p
>< sup
cause mortality
without disabilities
study heterogeneity
sixteen studies
data extraction
bias using
></ sup
<p>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. <a href="https://www.bmj.com/content/372/bmj.n71" target="_blank">https://www.bmj.com/content/372/bmj.n71</a>. This work is licensed under CC BY 4.0. To view a copy of this license, visit <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a>. For more information please see: <a href="https://www.prisma-statement.org/citing-prisma-2020" target="_blank">https://www.prisma-statement.org/citing-prisma-2020</a> – PRISMA.</p> <p>(DOCX)</p>
2026-09-30T17:57:04Z
Text
Journal contribution
10.1371/journal.pmed.1004947.s001
https://figshare.com/articles/journal_contribution/_p_PRISMA_2020_Checklist_p_/34036040
CC BY 4.0